Company Performance: Financial health, including revenue, profits, and debt levels, directly impacts investor confidence and share price. Strong performance typically leads to higher prices.

Industry Trends: The overall performance of the pharmaceutical industry, including growth rates and regulatory changes, can affect stock prices. Positive trends support higher valuations.

Market Sentiment: Broad market conditions, such as economic growth or recession, and investor risk appetite, influence stock prices. Optimistic markets generally boost stock prices.

Regulatory Environment: Government regulations and policies concerning drug pricing, approvals, and healthcare, significantly impact the profitability and future prospects of the company.

Competition: The competitive landscape, including the emergence of new players and the success of competing drugs, affects market share and profitability, impacting stock price.

Product Pipeline: The success of new drugs in development and their potential market value are crucial for future growth and affect investor sentiment.

Macroeconomic Factors: Inflation, interest rates, and currency exchange rates can impact the overall investment climate and influence stock valuations.